Frederiksberg, Denmark

Anne B Eldrup

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Frederiksberg, DK (2003)
  • Copenhagen, DK (2003)

Company Filing History:

goldMedal2 out of 834,307 
Other
 patents

Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Anne B Eldrup

Introduction

Anne B Eldrup is a notable inventor based in Frederiksberg, Denmark. She has made significant contributions to the field of peptide nucleic acids, holding 2 patents that showcase her innovative work. Her research focuses on the development of novel peptide nucleic acid (PNA) oligomers and their constituent monomers.

Latest Patents

Among her latest patents, Anne has developed peptide nucleic acid monomers and oligomers. These novel PNA oligomers and linked PNAs form triple-stranded structures with nucleic acids. They demonstrate an increased specificity for thymidine in nucleic acid targets compared to naturally occurring nucleobases. This advancement has the potential to enhance the precision of genetic targeting and manipulation.

Career Highlights

Throughout her career, Anne B Eldrup has established herself as a leading figure in her field. Her work has not only contributed to scientific knowledge but also paved the way for future innovations in genetic research and applications.

Collaborations

Anne has collaborated with esteemed colleagues such as Peter Eigil Nielsen and Gerald Haaima. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Anne B Eldrup's contributions to the field of peptide nucleic acids exemplify her innovative spirit and dedication to advancing scientific knowledge. Her patents reflect a commitment to enhancing the specificity of nucleic acid interactions, which could have far-reaching implications in biotechnology and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…